We are live on
!
Find out more
MAM
MPM Asset Management Portfolio holdings
AUM
$44.5M
1-Year Est. Return
47.28%
This Fund
S&P 500
This Quarter
Est. Return
+13.14%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$247M
AUM Growth
+$4.96M
(+2%)
Cap. Flow
-$3.56M
Cap. Flow
% of AUM
-1.44%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
–
Closed
2
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HSTO
Histogen Inc. Common Stock
HSTO
|
+$2.66M |
| 2 |
PETX
Aratana Therapeutics, Inc.
PETX
|
+$900K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
WCPI
BAM
WAMC
NLVP
CIEP
IPI
CC
VSAM
MPM Asset Management's Q2 2019 Portfolio in Review
As of Q2 2019, MPM Asset Management held 7 positions worth $247M, up 2% from $243M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
MPM Asset Management's Q2 2019 filing shows 2 closed positions. The largest sale was Histogen Inc. Common Stock, an estimated $2.66M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- MPM Asset Management fully exited Histogen Inc. Common Stock in Q2 2019, selling an estimated $2.66M.
- MPM Asset Management's ten largest holdings make up 100% of its $247M portfolio in Q2 2019.
- MPM Asset Management opened 0 new positions and closed 2 in Q2 2019.
- MPM Asset Management's portfolio value rose 2% quarter-over-quarter to $247M.
Based on MPM Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.